Pressure BioSciences, Inc. (US OTC:PBIO)
About the company
Pressure BioSciences, Inc. is engagedin the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. Its products includes high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, reagent kits, and service contracts. The firm offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme and BaroFlex, Strips,The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|IQVIA Holdings, Inc.||IQV||28104.12||11158.00||4.89||130.22||1.93|
|Laboratory Corp. of America Holdings||LH||17097.08||11587.00||2.42||54.18||2.77|
|Quest Diagnostics, Inc.||DGX||16037.12||7726.00||2.79||18.78||10.33|
|Syneos Health, Inc.||SYNH||6163.90||4720.00||2.03||31.26||4.13|
|National Research Corp.||NRC||1444.82||130.00||37.55||39.69||27.51|
|Apollo Medical Holdings, Inc.||AMEH||577.44||625.00||2.90||32.08||2.89|
|Bioanalytical Systems, Inc.||BASI||55.55||55.00||5.55||-24.05||-3.94|
|Protalix Biotherapeutics, Inc.||PLX||52.76||66.00||-3.70||-5.58||-14.18|
|Interpace Biosciences, Inc.||IDXG||20.76||27.00||3.07||-0.60||-121.14|
|Pressure BioSciences, Inc.||PBIO||4.50||2.00||-0.52||-0.28||-876.69|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
Pressure BioSciences First Quarter 2020 Financial and Business Update to Include Jim Morrison, In-Coming CEO for Merged Companies of Availa Bio
PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss ...
In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on ...
2020 Insider Inc. and finanzen.net GmbH All rights ... Made In NYC | Stock quotes by finanzen.net GO IN-DEPTH ON Pressure Biosciences STOCK Pressure Biosciences NewsMORE Quotes for Pressure ...
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries.
One such report from Grand View Research projected that the global biomarkers market size is expected to reach over USD 129.4 billion by 2027, exhibiting a CAGR of 13.7%, during the forecast period.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Pressure BioSciences' (OTC:PBIO +11.1% ... which arise through the buy-out of Cannaworx Inc. The merger is expected to close by June 30, after which the company will change its name to Availa ...